Tower Research Capital (TRC)’s Jade Biosciences, Inc. Common Stock JBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $30.9K | Buy |
3,089
+2,965
| +2,391% | +$29.6K | ﹤0.01% | 3376 |
|
|
2025
Q1 | $10.9K | Buy |
124
+14
| +13% | +$1.23K | ﹤0.01% | 3604 |
|
|
2024
Q4 | $10.2K | Sell |
110
-29
| -21% | -$2.7K | ﹤0.01% | 3823 |
|
|
2024
Q3 | $10.2K | Buy |
139
+21
| +18% | +$1.54K | ﹤0.01% | 3790 |
|
|
2024
Q2 | $6.88K | Buy |
118
+59
| +100% | +$3.44K | ﹤0.01% | 4527 |
|
|
2024
Q1 | $60.9K | Buy |
59
+33
| +127% | +$34.1K | ﹤0.01% | 2142 |
|
|
2023
Q4 | $20.9K | Sell |
26
-15
| -37% | -$12K | ﹤0.01% | 3618 |
|
|
2023
Q3 | $19.5K | Buy |
41
+15
| +58% | +$7.15K | ﹤0.01% | 3401 |
|
|
2023
Q2 | $15.6K | Sell |
26
-51
| -66% | -$30.5K | ﹤0.01% | 3601 |
|
|
2023
Q1 | $55K | Buy |
77
+44
| +133% | +$31.4K | ﹤0.01% | 2396 |
|
|
2022
Q4 | $34K | Sell |
33
-66
| -67% | -$68K | ﹤0.01% | 2628 |
|
|
2022
Q3 | $57K | Buy |
99
+84
| +560% | +$48.4K | ﹤0.01% | 3033 |
|
|
2022
Q2 | $8K | Sell |
15
-26
| -63% | -$13.9K | ﹤0.01% | 4654 |
|
|
2022
Q1 | $26K | Sell |
41
-48
| -54% | -$30.4K | ﹤0.01% | 3276 |
|
|
2021
Q4 | $37K | Buy |
89
+77
| +642% | +$32K | ﹤0.01% | 3014 |
|
|
2021
Q3 | $9K | Buy |
12
+5
| +71% | +$3.75K | ﹤0.01% | 4407 |
|
|
2021
Q2 | $5K | Buy |
+7
| New | +$5K | ﹤0.01% | 4682 |
|